Status:
COMPLETED
iEAT 2.0 Open Trial
Lead Sponsor:
Emory University
Conditions:
Gastrointestinal Disorders
Eligibility:
All Genders
12-6 years
Phase:
NA
Brief Summary
The purpose of this study is to learn more about the eating behaviors of children with chronic food refusal. Specifically, investigator's aim to see how the integrated Eating Aversion Treatment (iEAT)...
Detailed Description
This study seeks to further the development of iEAT by including participants that demonstrated improvements in a previously conducted pilot study, and finalize the treatment manual to include the sta...
Eligibility Criteria
Inclusion
- Present with partial food refusal as evidenced by greater than 75% of caloric needs met by bottle, formula, or tube feedings
- Have a medical history significant for an organic factor (e.g., gastrointestinal issues) which influenced the development of feeding concern
- Safe to consume up to 100% of his/her needs orally
- Parents of subjects must be English literate
- Ability to complete at least 2 structured meals each day
Exclusion
- Active medical diagnoses requiring hospitalization or significant oversight from a physician
- Active medical, structural, or functional limitations preventing safe oral intake of pureed foods
Key Trial Info
Start Date :
November 29 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 25 2019
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03383029
Start Date
November 29 2017
End Date
April 25 2019
Last Update
June 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30322